- Home
- Personal stories
Personal stories
What is an orphan drug?
The need for these rare disease therapies is strong, and access to them can be lifesaving. Here’s how Johnson & Johnson is innovating to help give patients options.
Learn about 3 health advocates who gather in NJ every year for empowerment and connection
In the quest to solve the toughest health challenges, innovating therapies and finding treatments are essential—but so is supporting the patients living with these diseases. That’s exactly why Johnson & Johnson launched HealtheVoices a decade ago.
What is cardiac ablation?
Learn how Johnson & Johnson is innovating to help treat the millions of people who are living with atrial fibrillation and other conditions that cause an irregular heartbeat.
Biomedical scientist Robert Langer receives the 2023 Dr. Paul Janssen Award for Biomedical Research
Each year, Johnson & Johnson honors a scientist currently working in academia, industry or a scientific institute who has made a significant contribution toward the improvement of public health.
Building health worker capacity to close the mental healthcare gap across Kenya
Kamili Organisation is working to make mental healthcare available at the primary care level by providing scholarships for mental health training, and driving a community-focused destigmatization campaign.
Johnson & Johnson named a 2024 Fortune World’s Most Admired Company
The company makes the list for the 22nd year in a row, thanks to its dedication to innovation, social responsibility and more.
